News from heartware international, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 01, 2015, 16:15 ET
HeartWare International, Inc.

HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd.

 HeartWare International, Inc. (Nasdaq: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are...

Aug 10, 2015, 08:00 ET

HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial

 HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are...

Aug 04, 2015, 12:16 ET

HeartWare Presentation At The Canaccord Genuity 35th Annual Growth Conference To Be Webcast

HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are...

Jul 30, 2015, 07:00 ET

HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth

 HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are...

Jul 21, 2015, 08:00 ET

HeartWare Schedules Second Quarter 2015 Conference Call And Webcast

HeartWare International, Inc. (NASDAQ:HTWR) has scheduled a conference call to discuss its financial results for the three months ended June 30,...

Jul 20, 2015, 19:14 ET

HeartWare International annonce les premiers implants sur des patients humains du système MVAD® dans le cadre d'un essai clinique international pour le marquage CE

- Le système MVAD est un système d'assistance circulatoire polyvalent, miniaturisé et avancé sur le plan hématologique,...

Jul 20, 2015, 17:52 ET

HeartWare International gibt erste Implantationen des MVAD®-Systems am Menschen in internationaler klinischen Studie für CE-Kennzeichnung bekannt

- Das MVAD-System ist ein vielseitiges, miniaturisiertes und hämatologisch fortschrittliches Kreislaufunterstützungssystem zur...

Jul 20, 2015, 13:49 ET

HeartWare International anuncia los primeros implantes humanos del sistema MVAD®

- HeartWare International anuncia los primeros implantes humanos del sistema MVAD® en un ensayo clínico internacional con la Marca CE -...

Jul 20, 2015, 07:00 ET
The MVAD(R) System, featuring the MVAD(R) Pump, is HeartWare's next-generation ventricular assist system and is a versatile, miniaturized and hematologically advanced circulatory assist system designed for full-support of patients with advanced heart failure.   CAUTION:  Investigational device.  Exclusively for clinical investigation.  Investigational device to be used by Qualified Investigators Only.

HeartWare International Announces First Human Implants Of The MVAD® System In CE Mark International Clinical Trial

HeartWare International, Inc. (Nasdaq: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are...

Jun 08, 2015, 17:30 ET

HeartWare International Issues Voluntary Device Correction

 HeartWare International, Inc. (NASDAQ: HTWR) issued a voluntary Urgent Medical Device Correction on May 11, 2015, describing five different...

Jun 04, 2015, 10:00 ET

HeartWare Presentation At The Goldman Sachs 36th Annual Global Healthcare Conference To Be Webcast

 HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are...

May 07, 2015, 08:52 ET

HeartWare Announces Private Placement Of $148 Million Of 1.75% Convertible Senior Notes Due 2021

 HeartWare International, Inc. (NASDAQ:HTWR), announced today that it has entered into privately-negotiated, exchange and subscription...

May 04, 2015, 09:00 ET

HeartWare Presentation At Bank Of America Merrill Lynch 2015 Health Care Conference To Be Webcast

 HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are...

Apr 30, 2015, 07:00 ET

HeartWare International Reports $70.0 Million In First Quarter 2015 Revenue

 HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are...

Apr 22, 2015, 13:00 ET

HeartWare Schedules First Quarter 2015 Conference Call And Webcast

 HeartWare International, Inc. (NASDAQ:HTWR) has scheduled a conference call to discuss its financial results for the three months ended March...

Apr 20, 2015, 16:30 ET

Contemporary Results From Commercial HVAD® System Registries Highlighted At ISHLT Meeting In Nice, France

HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are...

Apr 16, 2015, 04:20 ET
More than 8,000 advanced heart failure patients around the world have received the HeartWare(R) Ventricular Assist System featuring the HVAD(R) Pump - a small, full-support circulatory assist device designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices.  HeartWare announced today that data from its first destination therapy clinical trial cohort, ENDURANCE, successfully demonstrated that the trial achieved the primary endpoint...

HeartWare Achieves Primary Endpoint In The ENDURANCE Destination Therapy Clinical Trial

HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are...

Apr 10, 2015, 19:00 ET

HeartWare Announces Webcasts At The 35th International Society for Heart and Lung Transplantation Annual Meeting

 HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are...

Apr 09, 2015, 07:30 ET
The HeartWare(R) Ventricular Assist System featuring the HVAD(R) Pump has received approval from Health Canada for commercialization as a bridge to heart transplantation in patients with end-stage heart failure.  More than 8,000 advanced heart failure patients around the world have received this small, full-support circulatory assist device designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices.

HeartWare International Receives Health Canada Approval For Commercialization Of The HeartWare® Ventricular Assist System As A Bridge To Heart Transplantation

HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are...

Mar 04, 2015, 09:00 ET

HeartWare Presentation At The 2015 Barclays Global Healthcare Conference To Be Webcast

 HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are...